These findings further highlight the complex interplay among LEPR protein expression, adiposity, race, and breast tumor phenotype (55–58), which might require more precise adiposity measures, and identification and refinement of adiposity-associated biomarkers within breast tumor tissues that can predict breast cancer outcomes. The gene discussed is LEPR; the disease is breast cancer.